Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.

Fleischmann RM, Genovese MC, Enejosa JV, Mysler E, Bessette L, Peterfy C, Durez P, Ostor A, Li Y, Song IH.

Ann Rheum Dis. 2019 Nov;78(11):1454-1462. doi: 10.1136/annrheumdis-2019-215764. Epub 2019 Jul 30.

2.

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial.

Fleischmann R, Pangan AL, Song IH, Mysler E, Bessette L, Peterfy C, Durez P, Ostor AJ, Li Y, Zhou Y, Othman AA, Genovese MC.

Arthritis Rheumatol. 2019 Nov;71(11):1788-1800. doi: 10.1002/art.41032. Epub 2019 Aug 28.

PMID:
31287230
3.

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.

Tap WD, Gelderblom H, Palmerini E, Desai J, Bauer S, Blay JY, Alcindor T, Ganjoo K, Martín-Broto J, Ryan CW, Thomas DM, Peterfy C, Healey JH, van de Sande M, Gelhorn HL, Shuster DE, Wang Q, Yver A, Hsu HH, Lin PS, Tong-Starksen S, Stacchiotti S, Wagner AJ; ENLIVEN investigators.

Lancet. 2019 Aug 10;394(10197):478-487. doi: 10.1016/S0140-6736(19)30764-0. Epub 2019 Jun 19.

PMID:
31229240
4.

Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: The COMP-ACT MRI Substudy.

Peterfy C, Kremer J, Rigby W, Singer N, Birchwood C, Gill D, Reiss W, Pei J, Michalska M.

J Rheumatol. 2019 Jun 1. pii: jrheum.180953. doi: 10.3899/jrheum.180953. [Epub ahead of print]

5.

Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE).

Krabbe S, Eshed I, Gandjbakhch F, Pedersen SJ, Bird P, Mathew AJ, Lambert RG, Maksymowych WP, Glinatsi D, Stoenoiu MS, Poggenborg R, Jans L, Jaremko JL, Herregods N, Foltz V, Conaghan PG, Althoff CE, Paschke J, Peterfy C, Hermann KA, Østergaard M; for the OMERACT MRI in Arthritis Working Group.

J Rheumatol. 2019 Sep;46(9):1215-1221. doi: 10.3899/jrheum.181084. Epub 2019 Feb 15.

PMID:
30770508
6.

Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study.

Spitzer AI, Richmond JC, Kraus VB, Gomoll A, Jones DG, Huffman KM, Peterfy C, Cinar A, Lufkin J, Kelley SD.

Rheumatol Ther. 2019 Mar;6(1):109-124. doi: 10.1007/s40744-019-0140-z. Epub 2019 Feb 11.

7.

A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK, Levesque MC.

Arthritis Rheumatol. 2019 Jul;71(7):1056-1069. doi: 10.1002/art.40840. Epub 2019 Jun 7.

PMID:
30653843
8.

MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis.

Peterfy C, DiCarlo J, Emery P, Genovese MC, Keystone EC, Taylor PC, Schlichting DE, Beattie SD, Luchi M, Macias W.

J Rheumatol. 2019 Aug;46(8):887-895. doi: 10.3899/jrheum.171469. Epub 2019 Jan 15.

9.

Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS).

Kroon FPB, van Beest S, Gandjbakhch F, Peterfy CG, Chen S, Conaghan PG, Eshed I, Foltz V, Genant HK, Haugen IK, Medema JK, Østergaard M, Zhang L, Levesque MC, Kloppenburg M.

J Rheumatol. 2019 Sep;46(9):1228-1231. doi: 10.3899/jrheum.180949. Epub 2018 Dec 15.

PMID:
30554152
10.

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.

Kloppenburg M, Peterfy C, Haugen IK, Kroon F, Chen S, Wang L, Liu W, Levy G, Fleischmann RM, Berenbaum F, van der Heijde D, Bansal P, Wittoek R, Feng S, Fang Y, Saltarelli M, Medema JK, Levesque MC.

Ann Rheum Dis. 2019 Mar;78(3):413-420. doi: 10.1136/annrheumdis-2018-213336. Epub 2018 Dec 14.

11.

AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis.

Bird P, Peterfy C, Countryman P, Griffiths H, Barrett R, Youssef P, Joshua F, Hall S.

Int J Rheumatol. 2018 Apr 12;2018:8721753. doi: 10.1155/2018/8721753. eCollection 2018.

12.

Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS).

Kroon FPB, Peterfy CG, Conaghan PG, Foltz V, Gandjbakhch F, Eshed I, Genant HK, Østergaard M, Reijnierse M, Bloem JL, Haugen IK, Kloppenburg M.

RMD Open. 2018 Feb 8;4(1):e000583. doi: 10.1136/rmdopen-2017-000583. eCollection 2018. Erratum in: RMD Open. 2018 Apr 25;4(1):e000583corr1.

13.

Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.

Beals C, Baumgartner R, Peterfy C, Balanescu A, Mirea G, Harabagiu A, Popa S, Cheng A, Feng D, Ashton E, DiCarlo J, Vallee MH, Dardzinski BJ.

PLoS One. 2017 Dec 13;12(12):e0187397. doi: 10.1371/journal.pone.0187397. eCollection 2017.

14.

Effect of late prophylaxis in hemophilia on joint status: a randomized trial.

Manco-Johnson MJ, Lundin B, Funk S, Peterfy C, Raunig D, Werk M, Kempton CL, Reding MT, Goranov S, Gercheva L, Rusen L, Uscatescu V, Pierdominici M, Engelen S, Pocoski J, Walker D, Hong W.

J Thromb Haemost. 2017 Nov;15(11):2115-2124. doi: 10.1111/jth.13811. Epub 2017 Oct 10.

15.

The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT MRI in Arthritis Working Group.

Østergaard M, Peterfy CG, Bird P, Gandjbakhch F, Glinatsi D, Eshed I, Haavardsholm EA, Lillegraven S, Bøyesen P, Ejbjerg B, Foltz V, Emery P, Genant HK, Conaghan PG.

J Rheumatol. 2017 Nov;44(11):1706-1712. doi: 10.3899/jrheum.161433. Epub 2017 Aug 15.

16.

Whole-body Magnetic Resonance Imaging in Inflammatory Arthritis: Systematic Literature Review and First Steps Toward Standardization and an OMERACT Scoring System.

Østergaard M, Eshed I, Althoff CE, Poggenborg RP, Diekhoff T, Krabbe S, Weckbach S, Lambert RGW, Pedersen SJ, Maksymowych WP, Peterfy CG, Freeston J, Bird P, Conaghan PG, Hermann KG.

J Rheumatol. 2017 Nov;44(11):1699-1705. doi: 10.3899/jrheum.161114. Epub 2017 Jun 15. Review.

17.

Development and Validation of the OMERACT Rheumatoid Arthritis Magnetic Resonance Tenosynovitis Scoring System in a Multireader Exercise.

Glinatsi D, Bird P, Gandjbakhch F, Haavardsholm EA, Peterfy CG, Vital EM, Emery P, Conaghan PG, Østergaard M.

J Rheumatol. 2017 Nov;44(11):1688-1693. doi: 10.3899/jrheum.161097. Epub 2017 May 1.

18.

Development and Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System.

Kroon FPB, Conaghan PG, Foltz V, Gandjbakhch F, Peterfy C, Eshed I, Genant HK, Østergaard M, Kloppenburg M, Haugen IK.

J Rheumatol. 2017 Nov;44(11):1694-1698. doi: 10.3899/jrheum.161099. Epub 2017 Mar 1.

19.

Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting.

Waterton JC, Ho M, Nordenmark LH, Jenkins M, DiCarlo J, Guillard G, Roberts C, Buonaccorsi G, Parker GJM, Bowes MA, Peterfy C, Kellner H, Taylor PC.

Eur Radiol. 2017 Sep;27(9):3662-3668. doi: 10.1007/s00330-017-4736-9. Epub 2017 Jan 23.

20.

Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study.

Buch MH, Hensor EM, Rakieh C, Freeston JE, Middleton E, Horton S, Das S, Peterfy C, Tan AL, Wakefield RJ, Emery P.

Rheumatology (Oxford). 2017 Jan;56(1):58-67. doi: 10.1093/rheumatology/kew357. Epub 2016 Oct 22.

21.

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials.

Peterfy C, Strand V, Tian L, Østergaard M, Lu Y, DiCarlo J, Countryman P, Deodhar A, Landewé R, Ranganath VK, Troum O, Conaghan PG.

Ann Rheum Dis. 2017 Jun;76(6):992-997. doi: 10.1136/annrheumdis-2016-210311. Epub 2016 Dec 14.

PMID:
27974302
22.

Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis.

Peterfy C, Burmester GR, Bykerk VP, Combe BG, DiCarlo JC, Furst DE, Huizinga TW, Wong DA, Conaghan PG, Emery P.

Ann Rheum Dis. 2016 Aug;75(8):1501-5. doi: 10.1136/annrheumdis-2015-208258. Epub 2016 Feb 10.

23.

A 20 years of progress and future of quantitative magnetic resonance imaging (qMRI) of cartilage and articular tissues-personal perspective.

Eckstein F, Peterfy C.

Semin Arthritis Rheum. 2016 Jun;45(6):639-47. doi: 10.1016/j.semarthrit.2015.11.005. Epub 2015 Dec 1. Review.

PMID:
26767823
24.

Proceedings from The 8th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Conference.

Troum OM, Pimienta OL, Olech E, Østergaard M, Thiele R, Seraphine JL, Bruyn GA, Peterfy C.

Semin Arthritis Rheum. 2016 Jun;45(6):e17-23. doi: 10.1016/j.semarthrit.2015.09.007. Epub 2015 Oct 9.

PMID:
26614546
25.

Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the Hand and Foot in a Randomized Placebo-controlled Trial.

Glinatsi D, Bird P, Gandjbakhch F, Mease PJ, Bøyesen P, Peterfy CG, Conaghan PG, Østergaard M.

J Rheumatol. 2015 Dec;42(12):2473-9. doi: 10.3899/jrheum.141010. Epub 2015 Nov 1.

PMID:
26523032
26.

The Longitudinal Reliability and Responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS).

Haugen IK, Eshed I, Gandjbakhch F, Foltz V, Østergaard M, Bøyesen P, Bird P, Genant HK, Peterfy CG, Conaghan PG.

J Rheumatol. 2015 Dec;42(12):2486-91. doi: 10.3899/jrheum.140983. Epub 2015 Sep 1.

PMID:
26329336
27.

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.

Tap WD, Wainberg ZA, Anthony SP, Ibrahim PN, Zhang C, Healey JH, Chmielowski B, Staddon AP, Cohn AL, Shapiro GI, Keedy VL, Singh AS, Puzanov I, Kwak EL, Wagner AJ, Von Hoff DD, Weiss GJ, Ramanathan RK, Zhang J, Habets G, Zhang Y, Burton EA, Visor G, Sanftner L, Severson P, Nguyen H, Kim MJ, Marimuthu A, Tsang G, Shellooe R, Gee C, West BL, Hirth P, Nolop K, van de Rijn M, Hsu HH, Peterfy C, Lin PS, Tong-Starksen S, Bollag G.

N Engl J Med. 2015 Jul 30;373(5):428-37. doi: 10.1056/NEJMoa1411366.

28.

OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritis.

Hunter DJ, Arden N, Cicuttini F, Crema MD, Dardzinski B, Duryea J, Guermazi A, Haugen IK, Kloppenburg M, Maheu E, Miller CG, Martel-Pelletier J, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Roemer F, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):732-46. doi: 10.1016/j.joca.2015.03.003. Review.

29.

OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis.

Gold GE, Cicuttini F, Crema MD, Eckstein F, Guermazi A, Kijowski R, Link TM, Maheu E, Martel-Pelletier J, Miller CG, Pelletier JP, Peterfy CG, Potter HG, Roemer FW, Hunter DJ.

Osteoarthritis Cartilage. 2015 May;23(5):716-31. doi: 10.1016/j.joca.2015.03.004. Review.

30.

OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis.

Hunter DJ, Altman RD, Cicuttini F, Crema MD, Duryea J, Eckstein F, Guermazi A, Kijowski R, Link TM, Martel-Pelletier J, Miller CG, Mosher TJ, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Raynauld JP, Roemer FW, Totterman SM, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):698-715. doi: 10.1016/j.joca.2015.03.012. Review. Erratum in: Osteoarthritis Cartilage. 2015 Aug; 23(8):1434-5.

31.

Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conference.

Troum OM, Pimienta OL, Schmidt WA, Ostergaard M, D'Agostino MA, Gaylis N, Arnold W, Ben-Artzi A, Ranganath V, Seraphine JL, Peterfy C.

Semin Arthritis Rheum. 2015 Aug;45(1):115-21. doi: 10.1016/j.semarthrit.2015.02.011. Epub 2015 Mar 3. Review.

PMID:
25908178
32.

Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal Trial.

Glinatsi D, Lillegraven S, Haavardsholm EA, Eshed I, Conaghan PG, Peterfy C, Gandjbakhch F, Bird P, Bøyesen P, Døhn UM, Genant HK, Østergaard M.

J Rheumatol. 2015 Dec;42(12):2480-5. doi: 10.3899/jrheum.141009. Epub 2015 Feb 15.

PMID:
25684773
33.

The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities.

Østergaard M, Bird P, Gandjbakhch F, Eshed I, Haugen IK, Haavardsholm EA, Lillegraven S, Foltz V, Glinatsi D, Peterfy C, Ejbjerg B, Bøyesen P, Mease PJ, Hermann KG, Emery P, Genant HK, Conaghan PG.

J Rheumatol. 2015 Dec;42(12):2470-2. doi: 10.3899/jrheum.141248. Epub 2015 Feb 15. Review.

PMID:
25684771
34.

Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis.

Westhovens R, Robles M, Ximenes AC, Wollenhaupt J, Durez P, Gomez-Reino J, Grassi W, Haraoui B, Shergy W, Park SH, Genant H, Peterfy C, Becker JC, Murthy B.

Ann Rheum Dis. 2015 Mar;74(3):564-8. doi: 10.1136/annrheumdis-2014-206149. Epub 2014 Dec 30.

35.

Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

MacIsaac KD, Baumgartner R, Kang J, Loboda A, Peterfy C, DiCarlo J, Riek J, Beals C.

PLoS One. 2014 Dec 12;9(12):e113937. doi: 10.1371/journal.pone.0113937. eCollection 2014.

36.

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.

Peterfy C, Emery P, Tak PP, Østergaard M, DiCarlo J, Otsa K, Navarro Sarabia F, Pavelka K, Bagnard MA, Gylvin LH, Bernasconi C, Gabriele A.

Ann Rheum Dis. 2016 Jan;75(1):170-7. doi: 10.1136/annrheumdis-2014-206015. Epub 2014 Oct 29.

37.

Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.

Kremer JM, Peterfy C, Russell AS, Emery P, Abud-Mendoza C, Sibilia J, Becker JC, Westhovens R, Genant HK.

J Rheumatol. 2014 Jun;41(6):1077-87. doi: 10.3899/jrheum.130263. Epub 2014 May 1.

38.

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.

Conaghan PG, Peterfy C, Olech E, Kaine J, Ridley D, Dicarlo J, Friedman J, Devenport J, Troum O.

Ann Rheum Dis. 2014 May;73(5):810-6. doi: 10.1136/annrheumdis-2013-204762. Epub 2014 Feb 13.

39.

Update on the OMERACT magnetic resonance imaging task force: research and future directions.

Conaghan PG, McQueen FM, Bird P, Peterfy C, Haavardsholm E, Gandjbakhch F, Eshed I, Haugen IK, Lillegraven S, Døhn UM, Ejbjerg B, Foltz V, Coates L, Bøyesen P, Hermann KG, Freeston J, Lassere M, O'Connor P, Emery P, Genant H, Østergaard M.

J Rheumatol. 2014 Feb;41(2):383-5. doi: 10.3899/jrheum.131085. Epub 2013 Dec 1.

PMID:
24293579
40.

Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system.

Haugen IK, Østergaard M, Eshed I, McQueen FM, Bird P, Gandjbakhch F, Foltz V, Genant H, Peterfy C, Lillegraven S, Haavardsholm EA, Bøyesen P, Conaghan PG.

J Rheumatol. 2014 Feb;41(2):386-91. doi: 10.3899/jrheum.131086. Epub 2013 Dec 1.

41.

The OMERACT-RAMRIS rheumatoid arthritis magnetic resonance imaging joint space narrowing score: intrareader and interreader reliability and agreement with computed tomography and conventional radiography.

Døhn UM, Conaghan PG, Eshed I, Boonen A, Boyesen P, Peterfy CG, Lillegraven S, Ejbjerg B, Gandjbakhch F, Bird P, Foltz V, Genant HK, Haavardsholm E, McQueen FM, Østergaard M.

J Rheumatol. 2014 Feb;41(2):392-7. doi: 10.3899/jrheum.131087. Epub 2013 Dec 1.

PMID:
24293568
42.

What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?

Pelletier JP, Cooper C, Peterfy C, Reginster JY, Brandi ML, Bruyère O, Chapurlat R, Cicuttini F, Conaghan PG, Doherty M, Genant H, Giacovelli G, Hochberg MC, Hunter DJ, Kanis JA, Kloppenburg M, Laredo JD, McAlindon T, Nevitt M, Raynauld JP, Rizzoli R, Zilkens C, Roemer FW, Martel-Pelletier J, Guermazi A.

Ann Rheum Dis. 2013 Oct;72(10):1594-604. doi: 10.1136/annrheumdis-2013-203631. Epub 2013 Jul 25. Review. Erratum in: Ann Rheum Dis. 2017 May 25;:.

PMID:
23887285
43.

Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932).

Peterfy CG, Olech E, DiCarlo JC, Merrill JT, Countryman PJ, Gaylis NB.

Arthritis Res Ther. 2013 Mar 20;15(2):R44. doi: 10.1186/ar4202.

44.

Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual Conference.

Conaghan PG, Ostergaard M, D'Agostino MA, Gaylis N, Arnold W, Olech E, Wells A, Peterfy C, Seraphine JL, Troum O.

Semin Arthritis Rheum. 2013 Feb;42(4):433-46. doi: 10.1016/j.semarthrit.2012.10.003.

PMID:
23415135
45.

MRI comes of age in RA clinical trials.

Peterfy C, Østergaard M, Conaghan PG.

Ann Rheum Dis. 2013 Jun;72(6):794-6. doi: 10.1136/annrheumdis-2012-202696. Epub 2013 Jan 23.

PMID:
23345597
46.

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial.

Conaghan PG, Durez P, Alten RE, Burmester GR, Tak PP, Klareskog L, Catrina AI, DiCarlo J, Gaillez C, Le Bars M, Zhou X, Peterfy C.

Ann Rheum Dis. 2013 Aug;72(8):1287-94. doi: 10.1136/annrheumdis-2012-201611. Epub 2012 Aug 21.

47.

Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI.

Peterfy CG, DiCarlo JC, Olech E, Bagnard MA, Gabriele A, Gaylis N.

Arthritis Res Ther. 2012 May 30;14(3):R131. doi: 10.1186/ar3861.

48.

Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study.

Saleem B, Brown AK, Quinn M, Karim Z, Hensor EM, Conaghan P, Peterfy C, Wakefield RJ, Emery P.

Ann Rheum Dis. 2012 Aug;71(8):1316-21. doi: 10.1136/annrheumdis-2011-200548. Epub 2012 Jan 31.

PMID:
22294638
49.

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE.

Tak PP, Rigby W, Rubbert-Roth A, Peterfy C, van Vollenhoven RF, Stohl W, Healy E, Hessey E, Reynard M, Shaw T.

Ann Rheum Dis. 2012 Mar;71(3):351-7. doi: 10.1136/annrheumdis-2011-200170. Epub 2011 Oct 19.

50.

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.

Kremer JM, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Westhovens R, Li T, Zhou X, Becker JC, Aranda R, Peterfy C, Genant HK.

Ann Rheum Dis. 2011 Oct;70(10):1826-30. doi: 10.1136/ard.2010.139345.

Supplemental Content

Loading ...
Support Center